Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Why MTaI doesnt support self-regulation proposal of AISNMA

      Why MTaI doesn't support self-regulation proposal of AISNMA

      Ruby Khatun Khatun5 March 2018 1:27 PM IST
      New Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
      Last chance for medical devices firms to submit price data: NPPA

      Last chance for medical devices firms to submit price data: NPPA

      Ruby Khatun Khatun5 March 2018 11:00 AM IST
      New Delhi: National drug pricing regulator NPPA has said medical devices makers and importers are being given the last opportunity to submit data...
      Aurobindo Pharma shares fall 5 percent on reports of USFDA observations

      Aurobindo Pharma shares fall 5 percent on reports of USFDA observations

      Ruby Khatun Khatun5 March 2018 10:45 AM IST
      New Delhi: Shares of Aurobindo Pharma Ltd slumped more than 5% in morning trade amid reports that the company has received observations from the US...
      Fortis Healthcare gets notice from fraud investigation office seeking information

      Fortis Healthcare gets notice from fraud investigation office seeking information

      Ruby Khatun Khatun5 March 2018 10:30 AM IST
      New Delhi: Fortis Healthcare said it has received a notice from Serious Fraud Investigation Office asking for certain information and documents to be...
      Merck turns to tumor-killing viruses in immune cancer treatment: Report

      Merck turns to tumor-killing viruses in immune cancer treatment: Report

      Ruby Khatun Khatun5 March 2018 9:45 AM IST
      Scientists have tried to muster viruses to hunt and kill tumors for almost 70 years, with limited success. That may be changing.Now, microbes are...
      DSM launches sale of anti-infectives maker DSP: sources

      DSM launches sale of anti-infectives maker DSP: sources

      Ruby Khatun Khatun5 March 2018 9:30 AM IST
      FRANKFURT: Dutch specialty chemicals company DSM has launched the sale of its anti-infectives unit DSM Sinochem Pharmaceuticals (DSP), a potential 640...
      Startup eyeing Alzheimers cure worth 2.5 billion dollars: Report

      Startup eyeing Alzheimer's cure worth 2.5 billion dollars: Report

      Ruby Khatun Khatun4 March 2018 10:30 AM IST
      It hasn’t found a cure for Alzheimer’s disease and doesn’t have any drugs on the market. Yet, TauRx Pharmaceuticals Ltd. says the company’s worth...
      Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta

      Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta

      Ruby Khatun Khatun4 March 2018 10:15 AM IST
      Biogen Inc and AbbVie Inc have withdrawn their multiple sclerosis drug, the companies said, following reports of eight cases of inflammation of the...
      Hyderabad University launches biggest Bio-Incubator facility

      Hyderabad University launches biggest Bio-Incubator facility

      Ruby Khatun Khatun4 March 2018 10:00 AM IST
      Hyderabad: The largest Bio-Incubator facility in Hyderabad, perhaps in India, with 20000 square feet built-up area was inaugurated at School of Life...
      Natco Pharma seeks USFDA approval for hepatitis drug

      Natco Pharma seeks USFDA approval for hepatitis drug

      Ruby Khatun Khatun4 March 2018 10:00 AM IST
      New Delhi: Drug firm Natco Pharma said it has filed an abbreviated new drug application (ANDA) for Sofosbuvir Tablets, 400mg, with the United States...
      Novo Holdings launches 165 million dollars superbug drug venture fund

      Novo Holdings launches 165 million dollars superbug drug venture fund

      Ruby Khatun Khatun4 March 2018 9:45 AM IST
      LONDON: A $165 million venture fund focused on tackling "superbugs" resistant to modern antibiotics has been launched to invest in small companies...
      Uber launches Uber Health in US

      Uber launches Uber Health in US

      Ruby Khatun Khatun4 March 2018 9:30 AM IST
      US: Whether it’s helping seniors regain their independence, providing newfound mobility to those living in underserved areas, or providing a safe...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok